annual operating profit:
-$344.18M+$17.18M(+4.75%)Summary
- As of today (June 29, 2025), IBRX annual operating income is -$344.18 million, with the most recent change of +$17.18 million (+4.75%) on December 31, 2024.
- During the last 3 years, IBRX annual operating profit has fallen by -$13.90 million (-4.21%).
- IBRX annual operating profit is now -120.28% below its all-time high of -$156.25 million, reached on December 31, 2019.
Performance
IBRX Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$64.43M+$4.97M(+7.16%)Summary
- As of today (June 29, 2025), IBRX quarterly operating income is -$64.43 million, with the most recent change of +$4.97 million (+7.16%) on March 31, 2025.
- Over the past year, IBRX quarterly operating profit has increased by +$30.77 million (+32.32%).
- IBRX quarterly operating profit is now -75.55% below its all-time high of -$36.70 million, reached on March 31, 2020.
Performance
IBRX quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$313.42M+$30.77M(+8.94%)Summary
- As of today (June 29, 2025), IBRX TTM operating income is -$313.42 million, with the most recent change of +$30.77 million (+8.94%) on March 31, 2025.
- Over the past year, IBRX TTM operating profit has increased by +$31.57 million (+9.15%).
- IBRX TTM operating profit is now -753.95% below its all-time high of -$36.70 million, reached on March 31, 2020.
Performance
IBRX TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
IBRX Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.8% | +32.3% | +9.2% |
| 3 y3 years | -4.2% | +32.9% | +7.8% |
| 5 y5 years | -120.3% | -75.5% | -754.0% |
IBRX Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | +4.8% | at high | +42.3% | at high | +15.7% |
| 5 y | 5-year | -120.3% | +4.8% | -75.5% | +42.3% | -754.0% | +15.7% |
| alltime | all time | -120.3% | +4.8% | -75.5% | +42.3% | -754.0% | +15.7% |
IBRX Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$64.43M(-7.2%) | -$313.42M(-8.9%) |
| Dec 2024 | -$344.18M(-4.8%) | -$69.40M(-13.5%) | -$344.18M(-4.2%) |
| Sep 2024 | - | -$80.25M(-19.2%) | -$359.29M(+0.0%) |
| Jun 2024 | - | -$99.33M(+4.3%) | -$359.17M(+4.1%) |
| Mar 2024 | - | -$95.20M(+12.7%) | -$344.98M(-4.5%) |
| Dec 2023 | -$361.36M(+3.1%) | -$84.50M(+5.4%) | -$361.36M(+0.1%) |
| Sep 2023 | - | -$80.14M(-5.9%) | -$361.08M(-2.9%) |
| Jun 2023 | - | -$85.14M(-23.7%) | -$371.75M(+1.5%) |
| Mar 2023 | - | -$111.58M(+32.5%) | -$366.23M(+4.5%) |
| Dec 2022 | -$350.62M | -$84.22M(-7.3%) | -$350.62M(+1.4%) |
| Sep 2022 | - | -$90.80M(+14.0%) | -$345.67M(+3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$79.62M(-17.0%) | -$333.70M(-1.8%) |
| Mar 2022 | - | -$95.97M(+21.1%) | -$339.99M(+2.9%) |
| Dec 2021 | -$330.28M(+57.1%) | -$79.27M(+0.6%) | -$330.28M(+3.7%) |
| Sep 2021 | - | -$78.84M(-8.2%) | -$318.39M(+8.0%) |
| Jun 2021 | - | -$85.91M(-0.4%) | -$294.77M(+13.5%) |
| Mar 2021 | - | -$86.26M(+28.0%) | -$259.78M(+23.6%) |
| Dec 2020 | -$210.22M(+34.5%) | -$67.39M(+22.0%) | -$210.22M(+47.2%) |
| Sep 2020 | - | -$55.22M(+8.4%) | -$142.84M(+63.0%) |
| Jun 2020 | - | -$50.92M(+38.7%) | -$87.62M(+138.7%) |
| Mar 2020 | - | -$36.70M | -$36.70M |
| Dec 2019 | -$156.25M | - | - |
FAQ
- What is ImmunityBio annual operating income?
- What is the all time high annual operating profit for ImmunityBio?
- What is ImmunityBio annual operating profit year-on-year change?
- What is ImmunityBio quarterly operating income?
- What is the all time high quarterly operating profit for ImmunityBio?
- What is ImmunityBio quarterly operating profit year-on-year change?
- What is ImmunityBio TTM operating income?
- What is the all time high TTM operating profit for ImmunityBio?
- What is ImmunityBio TTM operating profit year-on-year change?
What is ImmunityBio annual operating income?
The current annual operating profit of IBRX is -$344.18M
What is the all time high annual operating profit for ImmunityBio?
ImmunityBio all-time high annual operating income is -$156.25M
What is ImmunityBio annual operating profit year-on-year change?
Over the past year, IBRX annual operating income has changed by +$17.18M (+4.75%)
What is ImmunityBio quarterly operating income?
The current quarterly operating profit of IBRX is -$64.43M
What is the all time high quarterly operating profit for ImmunityBio?
ImmunityBio all-time high quarterly operating income is -$36.70M
What is ImmunityBio quarterly operating profit year-on-year change?
Over the past year, IBRX quarterly operating income has changed by +$30.77M (+32.32%)
What is ImmunityBio TTM operating income?
The current TTM operating profit of IBRX is -$313.42M
What is the all time high TTM operating profit for ImmunityBio?
ImmunityBio all-time high TTM operating income is -$36.70M
What is ImmunityBio TTM operating profit year-on-year change?
Over the past year, IBRX TTM operating income has changed by +$31.57M (+9.15%)